The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Occult hepatitis B virus infection: implications in transfusion
Open accessAbstract
Hepatitis B virus (HBV) presents a higher residual risk of transmission by transfusion than hepatitis C virus (HCV) or human immunodeficiency virus (HIV). While most infectious blood units are removed by screening for hepatitis B surface antigen (HBsAg), there is clear evidence that transmission by HBsAg‐negative components occurs, in part, during the serologically negative window period, but more so during the late stages of infection. Donations negative for HBsAg, but positive for HBV DNA, with or without the presence of HBV antibodies, correspond to ‘occult’ HBV infection (OBI). The frequency of OBI depends on the relative sensitivity of both HBsAg and HBV DNA assays. It also depends on the prevalence of HBV infection in the population. OBI may follow recovery from infection, displaying antibody to hepatitis B surface antigen (anti‐HBs) and persistent low‐level viraemia, escape mutants undetected by the HBsAg assays, or healthy carriage with antibodies to hepatitis B e antigen (anti‐HBe) and to hepatitis B core antigen (anti‐HBc). Over time, in the latter situation, anti‐HBe and, later, anti‐HBc may become undetectable. The critical question is whether or not OBI is infectious by transfusion. All forms have been shown to be infectious in immunocompromised individuals, such as organ‐ or bone marrow‐transplant recipients. In immunocompetent recipients, there is no evidence that anti‐HBs‐containing components (even at low titre) are infectious. Anti‐HBc only, with HBV DNA, can be associated with infectivity, as can rare cases of HBV DNA without any serological HBV marker. If HBV nucleic acid amplification technology (NAT) is considered, the OBI viral load would usually be < 500 IU/ml, making testing of plasma pools unsuitable unless the sensitivity of NAT significantly increases by genome enrichment or test improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease
Cacciola, I., Pollicino, T., Squadrito, G., Cerenzia, G., Orlando, M. E., & Raimondo, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410104 · Cited by 666
Bréchot, C., Thiers, V., Kremsdorf, D., Nalpas, B., Pol, S., & Paterlini-Bréchot, P. (2001) · Hepatology · doi:10.1053/jhep.2001.25172 · Cited by 560
Torbenson, M., & Thomas, D. L. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00345-6 · Cited by 533
Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen
Hoofnagle, J. H., Seeff, L. B., Buskell‐Bales, Z., Zimmerman, H. J., & the Veterans Administration Hepatitis Cooperative Study Group* (1978) · New England Journal of Medicine · doi:10.1056/nejm197806222982502 · Cited by 458
The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors
Wachs, M. E., Amend, W. J., Ascher, N. L., Bretan, P. N., Emond, J., Lake, J. R., Melzer, J. S., Roberts, J. P., Tomlanovich, S. J., Vincenti, F., et al. (1995) · Transplantation · doi:10.1097/00007890-199501000-00014 · Cited by 338
The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors
Wachs, M. E., Amend, W. J., Ascher, N. L., Bretan, P. N., Emond, J., Lake, J. R., Melzer, J. S., Roberts, J. P., Tomlanovich, S. J., Vincenti, F., et al. (1995) · Transplantation · doi:10.1097/00007890-199501270-00014 · Cited by 333
Hepatitis B virus persistence after recovery from acute viral hepatitis.
Michalak, T. I., Pasquinelli, C., Guilhot, S., & Chisari, F. V. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116950 · Cited by 330
KOZIOL, D. E., HOLLAND, P. V., ALLING, D. W., MELPOLDER, J. C., SOLOMON, R. E., PURCELL, R. H., HUDSON, L. M., SHOUP, F. J., KRAKAUER, H., & ALTER, H. J. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-488 · Cited by 328
Yamamoto, K., Horikita, M., Tsuda, F., Itoh, K., Akahane, Y., Yotsumoto, S., Okamoto, H., Miyakawa, Y., & Mayumi, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2671-2676.1994 · Cited by 307
Cited by
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J.-P., Brunetto, M. R., Buendia, M.-A., Chen, D.-S., Colombo, M., Craxì, A., Donato, F., Ferrari, C., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 833
Self-citationOccult hepatitis B virus infection
Raimondo, G., Pollicino, T., Cacciola, I., & Squadrito, G. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.007 · Cited by 543
Lin, L., Hanson, C. V., Alter, H. J., Jauvin, V., Bernard, K. A., Murthy, K. K., Metzel, P., & Corash, L. (2005) · Transfusion · doi:10.1111/j.0041-1132.2005.04316.x · Cited by 172
Metadata
- Authors
- Allain, J. ‐.
- Venue
- Vox Sanguinis
- Publisher
- Wiley
- Published
- 2004-02
- Volume
- 86
- Issue
- 2
- Pages
- 83-91
- ISSN
- 0042-9007 (ISSN-L)
- 1423-0410
- OpenAlex
- W2150141117
- Cited by
- 297
- References
- 33
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Occult hepatitis B virus infection: implications in transfusion. https://app.cochat.ai/papers/10.1111/j.0042-9007.2004.00406.x
- The paper
- Allain, J. ‐. (2004). Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis. https://doi.org/10.1111/j.0042-9007.2004.00406.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.